Srivastava, Pooja
Wang, Tiannan http://orcid.org/0000-0002-2983-7168
Clark, Beth Z.
Yu, Jing http://orcid.org/0000-0001-5331-6226
Fine, Jeffrey L. http://orcid.org/0000-0002-2678-8014
Villatoro, Tatiana M.
Carter, Gloria J.
Brufsky, Adam M. http://orcid.org/0000-0001-8080-7960
Gorantla, Vikram C.
Huggins-Puhalla, Shannon L.
Emens, Leisha A.
Basili, Thais http://orcid.org/0000-0003-3216-3544
da Silva, Edaise M. http://orcid.org/0000-0003-3281-7333
Reis-Filho, Jorge S. http://orcid.org/0000-0003-2969-3173
Bhargava, Rohit http://orcid.org/0000-0002-1225-8418
Article History
Received: 3 December 2021
Accepted: 22 March 2022
First Online: 20 April 2022
Competing interests
: J. S. R.-F. reports receiving personal/consultancy fees from Goldman Sachs, REPARE Therapeutics, Paige.AI and Eli Lilly, membership of the scientific advisory boards of VolitionRx, REPARE Therapeutics, Paige.AI and Personalis, membership of the Board of Directors of Grupo Oncoclinicas, and ad hoc membership of the scientific advisory boards of Roche Tissue Diagnostics, Ventana Medical Systems, Novartis, Genentech and InVicro, outside the scope of this study. J. L. F. is co-founder with equity, SpIntellx Inc., Pittsburgh, PA. R. B. is consultant in Agilent Technologies.
: The study was approved by the University of Pittsburgh Institutional Review Board with waiver of the informed consent.